CERo Therapeutics (CERO) News Today $0.25 -0.01 (-3.86%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period 3 Penny Stocks to Watch Now, 11/19/24November 19 at 8:40 AM | msn.comCero Therapeutics receives FDA clearance of IND application for CER-1236November 16, 2024 | markets.businessinsider.comBioventures Opportunities G. Yk Sells 3,250,000 Shares of CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) StockNovember 15, 2024 | insidertrades.comCERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous LeukemiaNovember 15, 2024 | globenewswire.comCero Therapeutics presents preclinical data on CER-1236November 13, 2024 | markets.businessinsider.comCERo Therapeutics’ (CERO) Stock Sees Significant Climb After Revealing Ovarian Cancer DataNovember 13, 2024 | msn.comCERo Therapeutics Stock Is Soaring Monday: What's Going On?November 11, 2024 | benzinga.comCERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without ToxicityNovember 11, 2024 | globenewswire.comCero Therapeutics submits IND clinical hold CRL to the FDAOctober 22, 2024 | markets.businessinsider.comCERo Therapeutics files to sell 713.6M shares of common stock for holdersOctober 21, 2024 | msn.comCERo Therapeutics, Inc. Provides Corporate UpdateOctober 21, 2024 | globenewswire.comCERo Therapeutics appoints new CFO and CDOOctober 4, 2024 | investing.comCERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development OfficerOctober 2, 2024 | globenewswire.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News SummarySeptember 25, 2024 | benzinga.comCERo Therapeutics Hldgs (NASDAQ:CERO) Stock, Short Interest ReportSeptember 25, 2024 | benzinga.comDow Tumbles Over 200 Points; CERo Therapeutics Shares JumpSeptember 25, 2024 | msn.comCERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236September 25, 2024 | globenewswire.comMarinus Pharmaceuticals, Inc. (61Y.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comCERo Therapeutics Holdings, Inc. (CERO)August 25, 2024 | finance.yahoo.comCERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236June 13, 2024 | globenewswire.comCERo Therapeutics Holdings, Inc.: CERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 15, 2024 | finanznachrichten.deCERo Therapeutics, Inc. Provides Corporate Update for ShareholdersMay 15, 2024 | globenewswire.comCERO CERo Therapeutics Holdings, Inc.May 9, 2024 | seekingalpha.comCERo Therapeutics, Inc. Presents Encouraging Preclinical Data for AML on CER-1236 at Stanford Drug Discovery Symposium Highlighting Tumor Elimination and Manufacturing AttributesApril 30, 2024 | finance.yahoo.comCompare with Bloomberg Emerging Markets Large & Mid Cap Total Return Index NOK (EMTK)March 30, 2024 | msn.comCERo Therapeutics Holdings Inc.March 21, 2024 | wsj.comCERo Therapeutics Holdings Inc CEROMarch 17, 2024 | morningstar.comCERo Therapeutics, Inc. Announces Publication of Preclinical Research Supporting the Use of Its Clinical Candidate CER-1236 to Treat AML PatientsMarch 11, 2024 | finance.yahoo.comTrading was temporarily halted for "CERO" at 09:03 AM with a stated reason of "LULD pause."March 7, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 26, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 22, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 12:02 PM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 11:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 11:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 10:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 09:02 AM with a stated reason of "LULD pause."February 16, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause." Trading set to resume at 02:02 PM. February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 02:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 01:02 PM with a stated reason of "LULD pause." Trading set to resume at 01:02 PM. February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 12:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 12:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.comTrading was temporarily halted for "CERO" at 12:02 PM with a stated reason of "LULD pause."February 15, 2024 | marketbeat.com Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide CERO Media Mentions By Week CERO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERO News Sentiment▼-0.150.46▲Average Medical News Sentiment CERO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERO Articles This Week▼61▲CERO Articles Average Week Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ELDN News CKPT News BDTX News IVA News ABOS News ELUT News FTLF News IXHL News SGMT News CRDL News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERO) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CERO Stock Alerts